Hemodynamic InstabilityVasinNCT06355635
Application and Monitoring of Vasoactive and Inotrope Drugs
An observational study of Hemodynamic Instability, run by Johannes Gutenberg University Mainz at 1 site in Germany.
Trial summary
The investigators aimed to establish current practice of application and monitoring of vasoactive and inotrope Drugs in non-cardiac surgery patients. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Hemodynamic Instability
- What is being tested?
- Choice and Monitoring
- How many people
- 1,000 participants
- Where
- 1 siteGermany
- Study dates
- 4 Apr 2024to 1 Nov 2024
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Child, Adult, Older adult
Study population: All Anesthesiologists
Who may be able to join
- all anesthesiologists of germany
Who cannot join
- not completely responses
Trial locations and contacts
1 site in 1 country.
Germany1 site, 1 recruiting
- Recruiting
Department of Anaesthesiology;
Mainz, Rhineland-Palatinate, D55131
Marc Kriege, MD, 00496131170, MaKriege@uni-mainz.de
About this study
Official title: Evaluation of Application and Monitoring of Vasoactive and Inotrope Drugs in Non-cardiac Surgery Patients
The investigators aimed to establish current practice of application and monitoring of vasoactive and inotrope Drugs in non-cardiac surgery patients.
Read the detailed description
This survey provides a current update on a variety of cardioactive and vasoactive drugs at non-cardiac surgery patients in germany.
- Conditions
- Hemodynamic Instability
- Being tested
- Choice and Monitoring
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Choice and MonitoringOther
Also called current practice
current practive of vasoactive and inotrope drugs
What is being measured
The primary outcome is the main question the study is designed to answer.
current practice of correct application and monitoring of vasoactive and inotrope Drugs
physiological parameter, Units on a scale
Measured: through study completion, an average of 2 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Apr 2024
- Study start4 Apr 2024
- Primary completion1 Jun 2024 (estimated)
- Study completion1 Nov 2024 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Hemodynamic InstabilityStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 1,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Johannes Gutenberg University Mainz
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Marc Kriege, MD, Johannes Gutenberg University Mainz
- Investigators
- Marc Kriege, Principal investigator, University Medical Centre
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06355635
- Sponsor's protocol ID
- JohannesGUVA
- Acronym
- Vasin
- Status last verified
- Apr 2024
- First submitted
- 16 Jun 2023
- Last updated
- 9 Apr 2024
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 9 Apr 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of Application and Monitoring of Vasoactive and Inotrope Drugs in Non-cardiac Surgery Patients
- ClinicalTrials.gov ID
- NCT06355635
- Acronym / sponsor ID
- Vasin / JohannesGUVA
- Conditions
- Hemodynamic Instability
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 1,000 participants (estimated)
- Lead sponsor
- Johannes Gutenberg University MainzUniversity, hospital or other
- Study start
- 4 Apr 2024 (actual)
- Primary completion
- 1 Jun 2024 (estimated)
- Study completion
- 1 Nov 2024 (estimated)
- First posted
- 9 Apr 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The investigators aimed to establish current practice of application and monitoring of vasoactive and inotrope Drugs in non-cardiac surgery patients.
Detailed description
This survey provides a current update on a variety of cardioactive and vasoactive drugs at non-cardiac surgery patients in germany.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Sex
- All
- Age groups
- Child, Adult, Older adult
- Study population
- All Anesthesiologists
Key inclusion criteria (1 listed)
- all anesthesiologists of germany
Key exclusion criteria (1 listed)
- not completely responses
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Choice and MonitoringAlso: current practicecurrent practive of vasoactive and inotrope drugs | Other | – |
Primary outcome
current practice of correct application and monitoring of vasoactive and inotrope Drugs
Time frame: through study completion, an average of 2 months
physiological parameter, Units on a scale
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Apr 2024.
- Individual participant dataSharing planned: No
Related trials for Hemodynamic Instability
Not yet recruitingObservational study
Diastolic Shock Index for Predicting Hemodynamic Instability During Continuous Renal Replacement Therapy
Acute Kidney Injury, Hypotension (MeSH: D007022)
Not yet recruitingObservational study
Ultrasound-Calibrated Pulse Contour Cardiac Output Monitoring: Value and Accuracy in Hemodynamic Care
Sepsis, Circulatory Instability
RecruitingObservational study
Comparison of PPV and LVOT VTI During Passive Leg Raising to Predict Fluid Responsiveness
Hemodynamic Instability, Hypovolemia
Not yet recruiting
Intracuff Dexmedetomidine Versus Alkalinized Lidocaine for Peri-Extubation Cough and Hemodynamic Responses in Elderly Patients
Airway Complication of Anesthesia, Hemodynamic Instability
RecruitingPhase 4
Effect of Remimazolam Versus Propofol Total Intravenous Anesthesia on Intraoperative Hemodynamic Stability in Patients Undergoing Thoracic or Abdominal Endovascular Aortic Repair
Aortic Aneurysm, Thoracoabdominal, Aortic Aneurysm, Abdominal
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Marc Kriege principal investigator
University Medical Centre
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Hemodynamic Instability, run by Johannes Gutenberg University Mainz at 1 site in Germany.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 9 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Marc Kriege, PhD (00496131170, makriege@uni-mainz.de), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
current practice of correct application and monitoring of vasoactive and inotrope Drugs (time frame: through study completion, an average of 2 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Apr 2024.